# Prevention of Breast Cancer-related Lymphedma With Tacrolimus

> **NCT04390685** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Odense University Hospital** · enrollment: 60 (actual)

## Conditions studied

- Lymphedema

## Interventions

- **DRUG:** Tacrolimus ointment

## Key facts

- **NCT ID:** NCT04390685
- **Lead sponsor:** Odense University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-26
- **Primary completion:** 2022-09
- **Final completion:** 2022-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2021-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04390685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04390685, "Prevention of Breast Cancer-related Lymphedma With Tacrolimus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04390685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*